I am very enthusiastic and believe in contributing to the future accessibility of innovative medicines, focusing on oncology and rare diseases. My background in pharmaceutical medicine provides insights into clinical outcomes and healthcare professionals' perspectives.🧬 As a 𝗛𝗲𝗮𝗹𝘁𝗵 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗣𝘂𝗯𝗹𝗶𝗰 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁 𝗮𝘁 𝗖𝗥𝗘𝗔𝗧𝗜𝗖 (Central European Advanced Therapy and Immunotherapy Centre), I participate in strategic discussions focused on optimizing the accessibility of Advanced Therapy Medicinal Products (ATMPs). My responsibilities include modeling early HTA and comprehensive market access plans for innovative therapies.📊 My professional journey includes hands-on experience as a 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿 𝗮𝘁 𝘁𝗵𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆 𝗗𝗲𝗽𝗮𝗿𝘁𝗺𝗲𝗻𝘁, 𝗠𝗘𝗗 𝗠𝗨𝗡𝗜. Simultaneously, I am pursuing a Ph.D. focusing on the 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 in collaboration with Masaryk Memorial Cancer Institute.🔬 Concurrently, I draw upon my experience as a 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗮𝘁 𝗖𝗭𝗘𝗖𝗥𝗜𝗡 (Czech Clinical Research Infrastructure Network). In this role, I oversee academic clinical trials, ensuring policy adherence and high-quality standards.